Flagship explainer

How Haemonetics Corporation makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$1.3B · 100%Cost of revenue$546M · 41%Gross profit$788M · 59%Operating income$157M · 12%Income before tax$128M · 10%Income tax$30.7M · 2%Net income$97.3M · 7%As of 2026-03-28 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$1.3B100%
Cost of revenue$546M41%
$788M59%
$157M12%
Income before tax$128M10%
Income tax$30.7M2%
$97.3M7%
Source: · event Mar 28, 2026 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full Haemonetics Corporation analysis at Buy Like Buffett